These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9567327)

  • 1. [Molecular modeling of N-isopropyl lisergamides analogous to LSD using molecular mechanics and quantum mechanical calculations].
    Cordero de Troconis MI; Pfaff R; Nichols D
    Acta Cient Venez; 1997; 48(2):85-90. PubMed ID: 9567327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug discrimination and receptor binding studies of N-isopropyl lysergamide derivatives.
    Huang X; Marona-Lewicka D; Pfaff RC; Nichols DE
    Pharmacol Biochem Behav; 1994 Mar; 47(3):667-73. PubMed ID: 8208787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling of the interaction of LSD and other hallucinogens with 5-HT2 receptors.
    Westkaemper RB; Glennon RA
    NIDA Res Monogr; 1994; 146():263-83. PubMed ID: 8742803
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).
    Halberstadt AL; Klein LM; Chatha M; Valenzuela LB; Stratford A; Wallach J; Nichols DE; Brandt SD
    Psychopharmacology (Berl); 2019 Feb; 236(2):799-808. PubMed ID: 30298278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD).
    Nichols DE; Frescas S; Marona-Lewicka D; Kurrasch-Orbaugh DM
    J Med Chem; 2002 Sep; 45(19):4344-9. PubMed ID: 12213075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective LSD-like activity in d-lysergic acid amides of (R)- and (S)-2-aminobutane.
    Oberlender R; Pfaff RC; Johnson MP; Huang XM; Nichols DE
    J Med Chem; 1992 Jan; 35(2):203-11. PubMed ID: 1732537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).
    Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Dowling G; Wallach J; Halberstadt AL
    Drug Test Anal; 2019 Aug; 11(8):1122-1133. PubMed ID: 31083768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
    Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
    J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSAR of agents involved in serotonin and LSD binding sites.
    Chan YL; Lien EJ; Shih JC
    NIDA Res Monogr; 1978; (22):103-13. PubMed ID: 30904
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychedelics without hallucinations?
    Service RF
    Science; 2022 Jan; 375(6579):370. PubMed ID: 35084949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD).
    Brandt SD; Kavanagh PV; Westphal F; Stratford A; Odland AU; Klein AK; Dowling G; Dempster NM; Wallach J; Passie T; Halberstadt AL
    Drug Test Anal; 2020 Jun; 12(6):812-826. PubMed ID: 32180350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural analysis of an lysergic acid diethylamide (LSD) analogue N-methyl-N-isopropyllysergamide (MiPLA): Insights from Rotamers in NMR spectra.
    Shoda T; Tsuji G; Kawamura M; Kurohara T; Misawa T; Kikura-Hanajiri R; Demizu Y
    Drug Test Anal; 2024 Jun; 16(6):588-594. PubMed ID: 37830386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action.
    Marona-Lewicka D; Nichols DE
    Pharmacol Biochem Behav; 2007 Oct; 87(4):453-61. PubMed ID: 17618679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of hydrophobicity in the antiserotonin activity of LSD analogs.
    Dunn WJ; Bederka JP
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):275-85. PubMed ID: 4818374
    [No Abstract]   [Full Text] [Related]  

  • 15. The frontier orbital phase angles: novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens.
    Clare BW
    J Med Chem; 1998 Sep; 41(20):3845-56. PubMed ID: 9748359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
    Cussac D; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Martel JC; Danty N; Rauly-Lestienne I
    Eur J Pharmacol; 2008 Oct; 594(1-3):32-8. PubMed ID: 18703043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the lysergic acid diethylamide analog, 1-(thiophene-2-carbonyl)-N,N-diethyllysergamide (1T-LSD) from a blotter product.
    Tanaka R; Kawamura M; Mizutani S; Kikura-Hanajiri R
    Drug Test Anal; 2024 May; 16(5):482-488. PubMed ID: 37605503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LSD, 5-HT (serotonin), and the evolution of a behavioral assay.
    Appel JB; West WB; Buggy J
    Neurosci Biobehav Rev; 2004 Jan; 27(8):693-701. PubMed ID: 15019419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantum chemical studies on drug actions. 3. Correlation of hallucinogenic and anti-serotonin activity of lysergic acid derivatives with quantum chemical data.
    Kumbar M; Sankar DV
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):65-100. PubMed ID: 4734018
    [No Abstract]   [Full Text] [Related]  

  • 20. The intracranial injection of drug in goldfish. I: Hallucinogens and their antagonism to smooth muscle activity.
    Abramson HA; Gettner HH; Carone PA; Rolo A; Krinsky L
    J Asthma Res; 1979 Jan; 16(2):55-61. PubMed ID: 287665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.